4.8 Article

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-09985-2

关键词

-

资金

  1. National Institutes of Health (NIH) [R01-GM110089, R21-EB021453]
  2. Medical Research Award
  3. W.M. Keck Foundation
  4. National Science Foundation (NSF GRFP)
  5. US National Institutes of Health K99/R00 Pathway to Independence Award from the National Institute of General Medical Sciences (NIGMS) [K99GM118909]
  6. Post 9/11 GI Bill

向作者/读者索取更多资源

The CRISPR-Cas9 system provides the ability to edit, repress, activate, or mark any gene (or DNA element) by pairing of a programmable single guide RNA (sgRNA) with a complementary sequence on the DNA target. Here we present a new method for small-molecule control of CRISPR-Cas9 function through insertion of RNA aptamers into the sgRNA. We show that CRISPR-Cas9-based gene repression (CRISPRi) can be either activated or deactivated in a dose-dependent fashion over a >10-fold dynamic range in response to two different small-molecule ligands. Since our system acts directly on each target-specific sgRNA, it enables new applications that require differential and opposing temporal control of multiple genes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据